The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for chronic lung disease bronchiectasis in the US. The regulator has set a ...

Bronchitis causes inflammation and narrowing of the bronchial tubes, which allows mucus to build up. Untreated COPD can lead to a faster progression of the disease, heart problems, and worsening ...

ARP Atlases. 2007;1:17-47. The total number of leukocytes recovered by lavage is determined by examination of a sample of the pooled fluid with a hemocytometer. The cell counts are most accurate ...

A ONCE-daily oral therapy targeting neutrophilic inflammation has shown promise in reducing exacerbations in patients with bronchiectasis, according to results from a large Phase 3 trial. The ...

Asthma medications can help improve symptoms. Your doctor may recommend treatment options that include OTC medications. Learn more about these options and whether they're appropriate for you.

The risk factors for these events are shared, such that increasing age, bronchial hyper-responsiveness, tobacco smoke exposure, asthma and lower respiratory infections/exacerbations are significant ...

Congenital lung malformations are rare disorders that emerge during a fetus’ development in the womb and are present at birth. Although usually one area of the lung is affected, the malformations can ...

Background: Identification of the risk factors for bronchial hyperresponsiveness (BHR) would increase the understanding of the causes of asthma. The relationship between physical activity and BHR in ...